Form 8-K - Current report:
SEC Accession No. 0001104659-21-001485
Filing Date
2021-01-06
Accepted
2021-01-06 16:02:14
Documents
14
Period of Report
2021-01-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm211743d1_8k.htm   iXBRL 8-K 28774
2 EXHIBIT 99.1 tm211743d1_ex99-1.htm EX-99.1 18539
6 GRAPHIC tm211743d1_img-001.jpg GRAPHIC 3440
  Complete submission text file 0001104659-21-001485.txt   233814

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA coll-20210106.xsd EX-101.SCH 3208
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE coll-20210106_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE coll-20210106_pre.xml EX-101.PRE 22725
7 EXTRACTED XBRL INSTANCE DOCUMENT tm211743d1_8k_htm.xml XML 3626
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37372 | Film No.: 21510449
SIC: 2834 Pharmaceutical Preparations